Concepedia

Author

Minnie Abromowitch

St. Jude Children's Research Hospital

Also Known As

M A Abromowitch, M Abromowitch, M. Abromowitch, Minnie A. Abromowitch, Minnie Abromowitch, William R. Crom

75

Publications

4.5K

Citations

36

H-Index

54

Concepts

All Affiliations

St. Jude Children's Research HospitalPalmetto Hematology OncologyUniversity of Nebraska Medical CenterUniversity of UtahUniversity of Southern California
MA

About

Minnie Abromowitch is an author at St. Jude Children's Research Hospital specializing in medicine, hematology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

23

1.8K

2

Immunology

9

9

580

3

Health Sciences

8

8

631

4

Public Health

1

1

42

5

Allergy

1

1

21

Minnie Abromowitch

×

52

Publications

3.9K

Citations

34

H-Index

YearCitations

Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy

Gaston K. Rivera, C‐H Pui, Minnie Abromowitch,

The Lancet

1991

387

Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.

S B Murphy, W. Paul Bowman, Minnie Abromowitch,

Journal of Clinical Oncology

1986

269

Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia

A. Thomas Look, PK Roberson, DL Williams,

Blood

1985

251

Outcome of children less than three years old at diagnosis with non‐metastatic medulloblastoma treated with chemotherapy on the “Head Start” I and II protocols

Girish Dhall, Howard Grodman, Lingyun Ji,

Pediatric Blood & Cancer

2008

236

Clinical and biologic hallmarks of the Philadelphia chromosome in childhood acute lymphoblastic leukemia

RC Ribeiro, Minnie Abromowitch, SC Raimondi,

Blood

1987

172

Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): Report of the Head Start I and II experience

Jason Fangusaro, Jonathan L. Finlay, Richard Sposto,

Pediatric Blood & Cancer

2007

139

Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease.

Melissa M. Hudson, Carol Greenwald, Elizabeth Thompson,

Journal of Clinical Oncology

1993

136

METHOTREXATE SYSTEMIC CLEARANCE INFLUENCES PROBABILITY OF RELAPSE IN CHILDREN WITH STANDARD-RISK ACUTE LYMPHOCYTIC LEUKAEMIA

WilliamE. Evans, ClintonF. Stewart, Chen‐Hsin Chen,

The Lancet

1984

119

Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: Final results of children's cancer group study 5941

Eric Lowe, Richard Sposto, Sherrie L. Perkins,

Pediatric Blood & Cancer

2008

115

Clinical pharmacodynamics of continuous infusion teniposide: systemic exposure as a determinant of response in a phase I trial.

John H. Rodman, Minnie Abromowitch, J A Sinkule,

Journal of Clinical Oncology

1987

115

Page 1